PPIDT00248
Drug Information
| Name | Raxibacumab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB08902 |
| Type | biotech |
| Indication | Raxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection | Intravenous |
50 mg/1mL
|